Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.
about
Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis.ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the diseaseA compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functionsAmyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction.Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat modelVentilatory control in ALS.Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders.Chronic mild stress for modeling anhedonia.Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.The interaction of genetics and environmental toxicants in amyotrophic lateral sclerosis: results from animal models.Slow intrathecal injection of rAAVrh10 enhances its transduction of spinal cord and therapeutic efficacy in a mutant SOD1 model of ALS.Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice.Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS.Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease.
P2860
Q27687180-48F12B56-7D7C-43EF-86E9-E8FAF0BDD785Q28392297-C2C93CD4-72FF-4C7A-AC22-5D01C0C028DEQ30627872-2520349A-4A94-4E8D-A0F0-E09996AD133EQ33711385-1265C8B0-266C-4C7C-A6CB-F9235EA790DFQ35092920-D82CF619-5255-4536-823C-9A287B6A4467Q36603298-4F869BB6-B8A1-48E2-94B1-F26F6D0B9099Q37031363-15043D0F-E959-4391-B6FC-E62F47C2C1CCQ37073110-7123B291-E1D3-4464-AE46-7E5D27375E53Q38108422-69972976-974A-48A5-BBD5-E6A04669461AQ38111142-74D906C7-9B8B-4BB5-9156-2E1CCB273A62Q38117081-65AB90D5-E4AD-4CCA-93D7-670852FCFFADQ38262690-BE4762FE-B3A2-49E8-B75A-784D6331DF12Q41043696-7E598C34-B195-47E9-831B-F05BB4CFF1E0Q41917952-63DFC652-7716-4D53-98D7-C929083A18B7Q47152662-6435E4FC-F957-41D9-A13C-A0523E3366A0Q47342302-638861AC-5A53-4F43-9139-AA902DDB9AF7Q48480002-BC807BCA-1FC1-41EF-BCD7-B02D775A0BDFQ53823794-4213C0F8-56D3-4BF5-8273-E13C080E9DA3
P2860
Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@en
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@nl
type
label
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@en
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@en
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@nl
P2093
P2860
P356
P1476
Neuromuscular junction protect ...... amyotrophic lateral sclerosis.
@en
P2093
Corey Macrander
Dan Krakora
Masatoshi Suzuki
P2860
P304
P356
10.1155/2012/379657
P577
2012-08-07T00:00:00Z